Literature DB >> 11673318

Visual and motor evoked potentials in the course of multiple sclerosis.

P Fuhr1, A Borggrefe-Chappuis, C Schindler, L Kappos.   

Abstract

While evoked potentials are sensitive tools for diagnosing multiple sclerosis, little is known about their prognostic value and their role in determining the course of the disease. To validate the visual and motor evoked potentials (VEP and MEP) as measures for the course of multiple sclerosis, we examined prospectively 30 patients with relapsing-remitting or secondary progressive multiple sclerosis. The Expanded Disability Status Scale (EDSS), VEP and MEP were measured at entry and after 6, 12 and 24 months. The Spearman rank correlation was used for statistical analysis. Applying multiple regression in 15 randomized patients allowed derivation of a formula for predicting changes in EDSS score based on changes in MEP and VEP. Validation was done by comparing the predicted with the real changes in EDSS in the other 15 patients. The number of pathological VEP and MEP results correlated at all four measurement points with the EDSS (rho > or = 0.6, P < or = 0.01). When the latencies of VEP and MEP were combined using the sum of their Z scores, correlation with the EDSS was even more significant (rho > or = 0.6, P < 0.001). Changes over time of electrophysiological data and EDSS were also correlated (rho = 0.43, P < 0.05). Moreover, VEP and MEP at baseline correlated with the EDSS after 2 years (rho = 0.43,P = 0.03). Reliable prediction of the course of multiple sclerosis for individual patients is not possible from VEP and MEP data. However, we conclude that, for groups of patients with secondary progressive or relapsing-remitting multiple sclerosis the combined testing of VEP and MEP yields numerical data that allow objective estimation of the course and prognosis of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11673318     DOI: 10.1093/brain/124.11.2162

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  25 in total

1.  Motor cortical reorganization is present after a single attack of multiple sclerosis devoid of cortico-spinal dysfunction.

Authors:  Audrey Rico; Wafaa Zaaraoui; Jerome Franques; Shahram Attarian; Françoise Reuter; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Jean Pouget; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva; Bertrand Audoin
Journal:  MAGMA       Date:  2010-12-17       Impact factor: 2.310

2.  Cortical excitability changes over time in progressive multiple sclerosis.

Authors:  Samar S Ayache; Alain Créange; Wassim H Farhat; Hela G Zouari; Catherine Lesage; Ulrich Palm; Mohammed Abdellaoui; Jean-Pascal Lefaucheur
Journal:  Funct Neurol       Date:  2015 Oct-Dec

Review 3.  Neurophysiological markers.

Authors:  Letizia Leocani; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

4.  Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Authors:  H Wiendl; K V Toyka; P Rieckmann; R Gold; H-P Hartung; R Hohlfeld
Journal:  J Neurol       Date:  2008-10-29       Impact factor: 4.849

5.  Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.

Authors:  Paolo Invernizzi; Laura Bertolasi; Maria Rachele Bianchi; Marco Turatti; Alberto Gajofatto; Maria Donata Benedetti
Journal:  J Neurol       Date:  2011-04-09       Impact factor: 4.849

6.  Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.

Authors:  L Leocani; M Rovaris; F M Boneschi; S Medaglini; P Rossi; V Martinelli; S Amadio; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-30       Impact factor: 10.154

Review 7.  Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Authors:  Carmen Tur; Marcello Moccia; Frederik Barkhof; Jeremy Chataway; Jaume Sastre-Garriga; Alan J Thompson; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2018-01-12       Impact factor: 42.937

8.  Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis.

Authors:  N Margaritella; L Mendozzi; M Garegnani; E Colicino; E Gilardi; L Deleonardis; F Tronci; L Pugnetti
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

9.  [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].

Authors:  Peter Rieckmann
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

10.  Altered cortical inhibitory function in children with spastic diplegia: a TMS study.

Authors:  Julia Vry; Michaela Linder-Lucht; Steffen Berweck; Ulrike Bonati; Maike Hodapp; Markus Uhl; Michael Faist; Volker Mall
Journal:  Exp Brain Res       Date:  2008-01-23       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.